Enhanced expression of mitochondrial folate cycle enzymes such as SHMT2, MTHFD2, and MTHFD1L was also detected in cancer cell lines using metabolic profiling, and this was associated with higher mortality in breast cancer patients63. This evidence concerns the gene MTHFD2 and breast carcinoma.